Decrotonylation of cGAS K254 prompts homologous recombination repair by blocking its DNA binding and releasing PARP1

被引:0
|
作者
Guo, Hejiang [1 ]
Han, Yang [1 ]
Yao, Shibo [1 ]
Chen, Bijia [1 ]
Zhao, Hongling [1 ]
Jia, Jin [1 ,2 ]
Chen, Shi [1 ,2 ]
Liu, Yuhao [1 ]
Gao, Shanshan [1 ]
Guan, Hua [1 ]
Lu, Jun [3 ]
Zhou, Ping-Kun [1 ,2 ]
机构
[1] Beijing Inst Radiat Med, Dept Radiat Biol, Beijing Key Lab Radiat Biol, Beijing, Peoples R China
[2] Univ South China, Sch Publ Hlth, Hengyang Med Sch, Hengyang, Hunan, Peoples R China
[3] Capital Med Univ, Beijing YouAn Hosp, Dept Med Oncol, Lab Clin Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
CROTONYLATION; SYNTHASE; SENSOR; DAMAGE; SIRT3;
D O I
10.1016/j.jbc.2024.107554
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclic GMP-AMP synthase (cGAS), a cytosolic DNA sensor, also exhibits nuclear genomic localization and is involved in DNA damage signaling. In this study, we investigated the impact of cGAS crotonylation on the regulation of the DNA damage response, particularly homologous recombination repair, following exposure to ionizing radiation (IR). Lysine 254 of cGAS is constitutively crotonylated by the CREB-binding protein; however, IR-induced DNA damage triggers sirtuin 3 (SIRT3)-mediated decrotonylation. Lysine 254 decrotonylation decreased the DNA-binding affinity of cGAS and inhibited its interaction with PARP1, promoting homologous recombination repair. Moreover, SIRT3 suppression led to homologous recombination repair inhibition and markedly sensitized cancer cells to IR and DNA-damaging chemicals, highlighting SIRT3 as a potential target for cancer therapy. Overall, this study revealed the crucial role of cGAS crotonylation in the lating cGAS and SIRT3 activities could be potential strategies for cancer therapy.
引用
收藏
页数:13
相关论文
共 24 条
  • [1] PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair
    Peng, Bin
    Shi, Ruifeng
    Bian, Jing
    Li, Yuwei
    Wang, Peipei
    Wang, Hailong
    Liao, Ji
    Zhu, Wei-Guo
    Xu, Xingzhi
    NUCLEIC ACIDS RESEARCH, 2021, 49 (13) : 7554 - 7570
  • [2] PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
    Wurster, Stephanie
    Hennes, Fabian
    Parplys, Ann C.
    Seelbach, Jasna I.
    Mansour, Wael Y.
    Zielinski, Alexandra
    Petersen, Cordula
    Clauditz, Till S.
    Muenscher, Adrian
    Friedl, Anna A.
    Borgmann, Kerstin
    ONCOTARGET, 2016, 7 (09) : 9732 - 9741
  • [3] MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
    Lai, Jinzhi
    Yang, Hainan
    Zhu, Yanyang
    Ruan, Mei
    Huang, Yayu
    Zhang, Qiuyu
    BMC CANCER, 2019, 19 (1)
  • [4] MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
    Jinzhi Lai
    Hainan Yang
    Yanyang Zhu
    Mei Ruan
    Yayu Huang
    Qiuyu Zhang
    BMC Cancer, 19
  • [5] Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation
    Bohi, Flurina
    Hottiger, Michael O.
    BIOMEDICINES, 2024, 12 (07)
  • [6] Multifaceted Role of PARP1 in Maintaining Genome Stability Through Its Binding to Alternative DNA Structures
    Laspata, Natalie
    Muoio, Daniela
    Fouquerel, Elise
    JOURNAL OF MOLECULAR BIOLOGY, 2024, 436 (01)
  • [7] The ATPase activity of Fml1 is essential for its roles in homologous recombination and DNA repair
    Nandi, Saikat
    Whitby, Matthew C.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (19) : 9584 - 9595
  • [8] Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells
    Sullivan-Reed, Katherine
    Toma, Monika M.
    Drzewiecka, Malgorzata
    Nieborowska-Skorska, Margaret
    Nejati, Reza
    Karami, Adam
    Wasik, Mariusz A.
    Sliwinski, Tomasz
    Skorski, Tomasz
    MOLECULAR CANCER RESEARCH, 2023, 21 (10) : 1017 - 1022
  • [9] PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway
    Li, Huafu
    Wang, Chunming
    Lan, Linxiang
    Wu, Wenhui
    Evans, Ian
    Ruiz, E. Josue
    Yan, Leping
    Zhou, Zhijun
    Oliveira, Joaquim M.
    Reis, Rui L.
    Hu, Zhenran
    Chen, Wei
    Behrens, Axel
    He, Yulong
    Zhang, Changhua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [10] PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination-Mediated DNA Repair
    Hu, Yiduo
    Petit, Sarah A.
    Ficarro, Scott B.
    Toomire, Kimberly J.
    Xie, Anyong
    Lim, Elgene
    Cao, Shiliang A.
    Park, Eunyoung
    Eck, Michael J.
    Scully, Ralph
    Brown, Myles
    Marto, Jarrod A.
    Livingston, David M.
    CANCER DISCOVERY, 2014, 4 (12) : 1430 - 1447